Comparison of three procedures for initial fitting of compression hearing aids. III. Inexperienced versus experienced users

International Journal of Audiology
Josephine MarriageJosé L Alcántara

Abstract

We assessed whether gain requirements differ for experienced users and new users when fitted with multi-band compression hearing aids Three procedures for initial fitting were used: the Cambridge method for loudness equalization (CAMEQ), the Cambridge method for loudness restoration (CAMREST), and the desired sensation level input/output (DSL[i/o]) method. Twenty experienced hearing aid users and 20 new users with mild-to-severe sensorineural loss were fitted with Danalogic 163D digital hearing aids, using each procedure in turn in a counter-balanced order. The new users were given a pre-fitting with slightly reduced gains prior to the 'formal' fitting. Immediately after formal fitting with a given procedure, and 1 week after fitting, the gains were adjusted by the minimum amount necessary to achieve acceptable fittings. The amount of adjustment required provided the main measure of the adequacy of the initial fitting. On average, new users required decreases in gain for all procedures, the decreases being larger for DSL[i/o] than for CAMEQ or CAMREST. For experienced users, gain adjustments were small for CAMEQ and CAMREST, but were larger and mostly negative for DSL[i/o]. After these gain adjustments, users wore the aids for ...Continue Reading

References

Aug 1, 1990·Hearing Research·B R Glasberg, B C Moore
Jun 1, 1973·The Journal of the Acoustical Society of America·E Villchur
May 1, 1981·The Journal of the Acoustical Society of America·R A Bladon, B Lindblom
Mar 1, 1995·The Journal of the Acoustical Society of America·L E CornelisseD G Jamieson
Apr 1, 1995·Ear and Hearing·R M Cox, G C Alexander
Feb 1, 1997·Ear and Hearing·A R Horwitz, C W Turner
Dec 9, 1998·British Journal of Audiology·B C Moore, B R Glasberg
Aug 4, 1999·Audiology : Official Organ of the International Society of Audiology·S O OlsenB V Borgkvist
Sep 16, 2000·Scandinavian Audiology·S ArlingerM Oberg
Sep 21, 2000·British Journal of Audiology·B C MooreJ I Alcántara
Aug 30, 2002·Journal of Speech, Language, and Hearing Research : JSLHR·Larry E HumesCarolyn Garner
Feb 21, 2004·International Journal of Audiology·José I AlcántaraJosephine Marriage

❮ Previous
Next ❯

Citations

Aug 7, 2014·The Journal of the Acoustical Society of America·Brian C J MooreBrian R Glasberg
Oct 17, 2015·International Journal of Audiology·Brian C J Moore, Aleksander Sęk
Jul 26, 2005·Auris, Nasus, Larynx·Monika Bertges Reber, Martin Kompis
Mar 28, 2006·International Journal of Audiology·Karolina SmedsChristopher Brew
Feb 16, 2010·International Journal of Audiology·Brian C J MooreMichael A Stone
Mar 28, 2006·International Journal of Audiology·Karolina SmedsChristopher Brew
Apr 25, 2012·Trends in Amplification·Lena L N Wong
Dec 7, 2011·Trends in Amplification·Monique Boymans, Wouter A Dreschler
Oct 24, 2007·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Mick MetselaarLouw Feenstra
Oct 17, 2008·International Journal of Audiology·Gitte KeidserIngrid Yeend
Feb 26, 2019·Trends in Hearing·Benjamin Caswell-Midwinter, William M Whitmer
Mar 19, 2019·Trends in Hearing·Trevor T PerryDianne J Van Tasell
Aug 5, 2005·International Journal of Audiology·Brian C J MooreBrian R Glasberg
Jun 8, 2010·Ear and Hearing·Brian C J Moore, Christian Füllgrabe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.